Cresset to expand sales pipeline through CambridgeSoft alliance
Cresset Biomolecular Discovery, of Welwyn Garden City, UK expects a distribution agreement signed with CambridgeSoft in Boston, US will lead to a dramatic increase in sales.
Cresset Biomolecular Discovery, of Welwyn Garden City, UK expects a distribution agreement signed with CambridgeSoft in Boston, US will lead to a dramatic increase in sales.
Under the terms of the agreement, CambridgeSoft sells Cresset's FieldAlign and FieldTemplater products to molecular modellers and medicinal chemists who want to discover new drugs against a range of biological targets. The products enable scientists to determine important interactions between ligands and proteins and to prioritise compounds for biological evaluation.
"The interest that Cambridgesoft has generated in our products is very encouraging, and I look forward to more organisations using these tools to develop new medicines," said Bea Leigh, chief executive of Cresset BioMolecular Discovery.
Michael Tomasic, president and chief executive of CambridgeSoft, added: "By delivering FieldAlign and FieldTemplater to CambridgeSoft customers through established business channels, we will extend the reach of these tools to a wider audience of scientists, and help them apply field technology to hit-finding, lead-switching, IP scanning, and portfolio management."
Cresset Biomolecular Discovery
T + 44 1707 356 120
b.leigh@cresset-bmd.com